Craft

BioLight

Stock Price

₪4.6

2024-10-29

Market Capitalization

₪2.2 B

2024-10-28

BioLight Summary

Company Summary

Overview
BioLight Life Sciences is an ophthalmic company focused on the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions. It includes glaucoma, dry eye syndrome, or DES, and age-related macular degeneration, or AMD.
Type
Public
Status
Active
Founded
2005
HQ
Tel Aviv-Yafo, IL | view all locations
Website
https://bio-light.co.il/
Cybersecurity rating
Sectors

Key People

  • Yaacov Michlin

    Yaacov Michlin, CEO

    • Eran Eilat

      Eran Eilat, CEO DiagnosTear

      • Israel Makov

        Israel Makov, Chairman

        • Suzana Nahum-Zilberberg

          Suzana Nahum-Zilberberg, Vice Chairman

          LocationsView all

          1 location detected

          • Tel Aviv-Yafo, Tel Aviv District HQ

            Israel

            Nissim Aloni St 10

          BioLight Financials

          Summary Financials

          Gross profit (FY, 2025)
          ₪180.0K
          Net income (FY, 2025)
          (₪16.9M)
          Cash (FY, 2025)
          ₪4.0M
          EBIT (FY, 2025)
          (₪15.7M)
          Enterprise value
          $2.2B

          Footer menu